IMMUNITYBIO, INC. Common Stock, Capital Shares Reserved for Future Issuance
IMMUNITYBIO, INC. (IBRX) had Common Stock, Capital Shares Reserved for Future Issuance of 12.60 million shares as of 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2021-05-14
- 2021-03-31: Common Stock, Capital Shares Reserved for Future Issuance 12.60M shares.
- 2020-12-31: Common Stock, Capital Shares Reserved for Future Issuance 7.10M shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 3.98M shares.
- 2019-12-31: Common Stock, Capital Shares Reserved for Future Issuance 8.87M shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 5.65M shares.
- 2019-06-30: Common Stock, Capital Shares Reserved for Future Issuance 7.25M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2021-03-31 | 12.60M shares 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 7.10M shares 8-K/A · filed 2021-04-22 | 3.98M shares 10-K · filed 2021-03-04 |
| 2019-12-31 | 8.87M shares 8-K/A · filed 2021-04-22 | 5.65M shares 10-K · filed 2020-03-25 |
| 2019-06-30 | 7.25M shares 10-Q · filed 2019-11-05 | |
| 2018-12-31 | 24.95M shares 10-K · filed 2019-03-13 | |
| 2017-12-31 | 24.30M shares 10-K · filed 2018-03-12 | |
| 2016-12-31 | 24.89M shares 10-K · filed 2017-03-15 | |
| 2015-12-31 | 2.13M shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |